MICHELLE DEVILBISS: Open Payments
NPI 1558827527 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,845 in 182 payments from 12 companies in 2025. Trend: 2023 $2,153 · 2024 $3,297 · 2025 $3,845
Food & beverage: $3,760Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 69 | $1,325 |
| Amgen Inc. | 47 | $654 |
| Novartis Pharmaceuticals Corporation | 19 | $649 |
| Janssen Biotech, Inc. | 30 | $545 |
| UCB, Inc. | 6 | $299 |
| Janssen Scientific Affairs, LLC | 1 | $103 |
| Lilly USA, LLC | 2 | $87 |
| E.R. Squibb & Sons, L.L.C. | 3 | $85 |
| GlaxoSmithKline, LLC. | 2 | $42 |
| PFIZER INC. | 1 | $24 |
Products named: RINVOQ, TREMFYA, Bimzelx, EVENITY, SKYRIZI, COSENTYX, OTEZLA, TAVNEOS.
Industry payments across OH — which companies pay providers there.
